The Fair Drug Pricing Act, Senate Bill S.131 & House Bill HR.2439

As an individual living for the past 33 years with the effects of MS, an MS activist, member of the Pennsylvania Government Relations Advisory Committee, inductee into the National MS Society Advocacy Hall of Fame and one who has witnessed the unsustainable rates of increase for all FDA approved MS therapies; I ask you to urge your Senators and Congressional Representatives to cosponsor and support Senate Bill 1131 or House of Representatives Bill 2439 a bill to require reporting regarding certain drug price increases (The fair drug pricing act). Simply shining light on the ever increasing price of chronic disease medications may well give the pharmaceutical industry reason to reconsider price increases that go directly to their bottom lines.